IN8bio
INAB
19 hedge funds and large institutions have $2.13M invested in IN8bio in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
58% more funds holding
Funds holding: 12 → 19 (+7)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
16% more capital invested
Capital invested by funds: $1.83M → $2.13M (+$298K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7.34% less ownership
Funds ownership: 28.93% → 21.59% (-7.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$169K |
| 2 |
Two Sigma Investments
New York
|
+$109K |
| 3 |
Two Sigma Advisers
New York
|
+$101K |
| 4 |
Jane Street
New York
|
+$57.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$54.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$313K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.49K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.02K |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$385 |
INAB Hedge Fund Activity: Q3 2025 in Review
19 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q3 2025, worth a combined $2.13M — up 16% from $1.83M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new INAB positions and 1 closed out — a net gain of 7 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $169K. The largest seller was AIGH Capital Management, exiting entirely with an estimated $313K sold.
- 19 institutional investors held IN8bio (INAB) as of Q3 2025, up from 12 in Q2 2025.
- Funds reported $2.13M of IN8bio stock for Q3 2025, up 16% quarter-over-quarter.
- 8 funds opened new IN8bio positions in Q3 2025 and 1 closed out, a net change of +7 holders.
- The largest IN8bio buyer in Q3 2025 was Stonepine Capital Management, an estimated $169K added.
- The largest IN8bio seller in Q3 2025 was AIGH Capital Management, an estimated $313K sold.
Based on aggregated 13F filings for Q3 2025.